MedAgentBench: A Virtual EHR Environment to Benchmark Medical LLM Agents | NEJM AI ai.nejm.org/doi/full/10.10…
Qaiser Bashir
Verified account This account is verified. Learn more@DQBMD
Stem Cell Transplantation | Myeloma | Leukemia | Clinical Trials | Personal views | Educator | Mentor
427 Following 1.5K Followers 769 Posts
Latest posts 5
Virtual twins for personalised CAR T-cell therapy in myeloma - The Lancet Haematology thelancet.com/journals/lanha…
FDA grants accelerated approval to linvoseltamab-gcpt for relapsed or refractory multiple myeloma
fda.gov/drugs/resource…
@FDAOncology
fda.gov/drugs/resource…
@FDAOncology
#asco2025 Update: JNJ-5322 is a next-gen T-cell redirecting bispecific antibody targeting BCMA + GPRC5D with low-affinity CD3 for improved safety. SubQ dosing Q2W or Q4W. Step-up dose (5 mg) used to reduce CRS risk. #MultipleMyeloma #Immunotherapy meetings.asco.org/abstracts-pres…
The BALANCE trial demonstrated that a 7-day antibiotic treatment strategy is non-inferior to a 14-day strategy for hospitalized patients with bloodstream infections.
Limitation in context of HCT: Pts with severe immunosuppression were excluded nejm.org/doi/full/10.10…
Limitation in context of HCT: Pts with severe immunosuppression were excluded nejm.org/doi/full/10.10…